Back to Search
Start Over
A qualitative exploration of pharmacovigilance policy implementation in Jordan, Oman, and Kuwait using Matland’s ambiguity-conflict model
- Source :
- Globalization and Health, Garashi, H, Steinke, D & Schafheutle, E 2021, ' A qualitative exploration of pharmacovigilance policy implementation in Jordan, Oman, and Kuwait using Matland's ambiguity-conflict model ', Globalization and Health, vol. 17, no. 97, pp. 1-15 . https://doi.org/10.1186/s12992-021-00751-y, Globalization and Health, Vol 17, Iss 1, Pp 1-15 (2021)
- Publication Year :
- 2021
- Publisher :
- BioMed Central, 2021.
-
Abstract
- Background As Arab countries seek to implement the ‘Guideline on Good Pharmacovigilance Practice (GVP) for Arab countries’, understanding policy implementation mechanisms and the factors impacting it can inform best implementation practice. This study aimed to explore the mechanisms of and factors influencing pharmacovigilance policy implementation in Arab countries with more established pharmacovigilance systems (Jordan, Oman), to inform policy implementation in a country with a nascent pharmacovigilance system (Kuwait). Results Matland’s ambiguity-conflict model served to frame data analysis from 56 face-to-face interviews, which showed that policy ambiguity and conflict were low in Jordan and Oman, suggesting an “administrative implementation” pathway. In Kuwait, policy ambiguity was high while sentiments about policy conflict were varied, suggesting a mixture between “experimental implementation” and “symbolic implementation”. Factors reducing policy ambiguity in Jordan and Oman included: decision-makers’ guidance to implementors, stakeholder involvement in the policy’s development and implementation, training of policy implementors throughout the implementation process, clearly outlined policy goals and means, and presence of a strategic implementation plan with appropriate timelines as well as a monitoring mechanism. In contrast, policy ambiguity in Kuwait stemmed from the absence or lack of attention to these factors. Factors reducing policy conflict included: the policy’s compliance with internationally recognised standards and the policy’s fit with local capabilities (all three countries), decision-makers’ cooperation with and support of the national centre as well as stakeholders’ agreement on policy goals and means (Jordan and Oman) and adopting a stepwise approach to implementation (Jordan). Conclusions Using Matland’s model, both the mechanism of and factors impacting successful pharmacovigilance policy implementation were identified. This informed recommendations for best implementation practice in Arab as well as other countries with nascent pharmacovigilance systems, including increased managerial engagement and support, greater stakeholder involvement in policy development and implementation, and undertaking more detailed implementation planning.
- Subjects :
- Oman
Process (engineering)
media_common.quotation_subject
Developing country
Adverse drug reactions
Developing countries
Pharmacovigilance
Political science
Humans
media_common
Social policy
Jordan
business.industry
Health Policy
Research
Arab World
Public Health, Environmental and Occupational Health
Health services research
Stakeholder
Timeline
Ambiguity
Public relations
Policy implementation
Policy
Kuwait
Public aspects of medicine
RA1-1270
business
Subjects
Details
- Language :
- English
- ISSN :
- 17448603
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Globalization and Health
- Accession number :
- edsair.doi.dedup.....ad2f784dd87ca8817e38975c3face1af